NA Proactive news snapshot: BioLargo, NexTech AR, Co-Diagnostics, Imagination Park UPDATE …

BioLargo Inc (OTCMKTS:BLGO) has initiated a regulated crowdfunding operation through its subsidiary BioLargo Water Investment Group Inc (BWIG) to secure the necessary funding to launch its patented water treatment technology into the $246 million poultry processing market. Nine billion chickens are processed in the US every year, the company said, which creates roughly 60 billion gallons of contaminated wastewater. BioLargo’s Advanced Oxidation System can treat the polluted water, allowing for safe wastewater discharge and water reuse. NexTech AR Solutions Corp (OTCMKTS:NEXCF) (CSE:NTAR) said that it has signed a contract to provide augmented reality technology to Steyr Arms USA, a top global firearms manufacturer. Steyr has been a pioneer in the firearms industry for over 150 years and now supplies products to over 50 of the world's militaries. With NexTech’s technology, Steyr Arms customers will be able to view firearms online in full 3D before making a purchase. Steyr Arms said an investment in augmented reality is an ideal way to connect with people who are browsing the company's products online. Co-Diagnostics Inc (NASDAQ:CODX) announced Wednesday it has received new orders for its vector control tests and equipment from mosquito abatement districts after participating in several vector control conferences. Recent conference appearances included a presentation at the 3rd International Conference on Zika Virus and Aedes Related Infections on February 13-16 in Washington, DC where Co-Diagnostics was well-received by the global audience.The conference provided a forum for the company to showcase its technology platform and a full suite of mosquito abatement tests to those in attendance, and to report on its rapid response to the outbreak of Covid-19 during the conference’s coronavirus symposia. Co-Diagnostics also says it is moving along to win regulatory OK to sell its coronavirus test for commercial use. Imagination Park Technologies Inc (CSE:IP) (OTCMKTS:IPNFF) has signed on as a sponsor of legendary boxing and UFC cutman Jacob "Stitch" Duran, who will be working Tyson Fury’s corner in his upcoming heavyweight championship rematch against Deontay Wilder. The role of the cutman is to tend to the injuries of a fighter between rounds and keep them healthy, both physically and mentally. In advance of the fight, Imagination Park has created a Stitch Duran AR model, which fans can pose with using the ImagineAR app. Users can place Stitch in their environment with the “AR Nearby!” feature, and the company is using the hashtag #StitchWithMe to give away a prize package to the best picture. Orgenesis Inc (NASDAQ:ORGS) announced a collaboration with Johns Hopkins University to utilize its point-of-care platform to develop and supply gene therapies and technologies. The company’s POCare cell therapy platform is designed to advance the development of Advanced Therapy Medicinal Products — medicines based on genes, tissues or cells — through collaborations and in-licensing with other companies. Johns Hopkins is the third major institution to sign an agreement with Orgenesis. Golden Arrow Resources Corporation (CVE:GRG) (OTCMKTS:GARWF) revealed that a drill program had kicked off at the Indiana gold-copper project in Chile - a near-term production target. Initial work includes a minimum of 2,500 metres in 12 holes, to test the Bondadosa, Flor de Espino and Rucas veins, the firm said. If successful, a further 2,500 metres is budgeted to test the site's broader potential. Berkwood Resources Ltd (CVE:BKR) will be exhibiting at the PDAC conference in Toronto, Ontario, the mining world’s leading industry event. The graphite explorer said it will be at Booth 2103 at the event, which runs from March 1 to 4 at the Metro Toronto Convention Centre in downtown Toronto. Berkwood is engaged in exploration for the commodities to enable the modern revolution in essential technologies such as energy storage systems and new electronics. Japan Gold Corp (CVE:JG) (OTCMKTS:JGLDF) has updated on exploration at its Kitano-o prospect on the island of Hokkaido, where it believes there is a large epithermal gold system. The prospect includes the Kitano mine and lies within a 7 by 4 km gold district which hosts seven additional gold prospects. The Kitano mine produced more than 96,000 ounces of gold at an average grade of 5.9 g/t primarily from shallow open-pits before it was closed by the Japanese government in 1943. "It is now interpreted that the western part of the Kitano-o Prospect represents the 'lateral outflow' of a large epithermal system, developed at depth in the eastern part of the 3 kilometre long prospect," the company said. Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) announced Wednesday that it will commence a Part 2 study of MAT2203 for the treatment of HIV patients with cryptococcal meningitis. The company’s move comes after the independent Data Safety Monitoring Board (DSMB) for the EnACT study completed its planned review of initial safety and tolerability data from the Part 1 dose-escalation phase of MAT2203. DSMB has unanimously approved proceeding with enrollment in the Part 2 efficacy phase at 2 grams of drug daily, the highest dose tested in Part 1. Codebase Ventures Inc's (CSE:CODE) (OTCMKTS:BKLLF) blockchain subsidiary Arcology is testing a popular Ethereum-based game called CryptoKitties on its own internal network.  The game, which lets players buy and sell digital kittens using ethereum, can cause major network congestion because of its high transaction volume. Osino Resources Corp (CSE:OSI) is advancing its Twin Hills Central (THC) discovery in Nambia to the maiden resource stage and aims to start a third phase of drilling there before the end of the first quarter this year. As reported last month, the firm said latest holes at THC had increased the strike length of confirmed gold by 50% to 1,200 metres (m) from 800 m previously. "Early modelling at Twin Hills Central indicates significant resource size potential and the focus will now be to better define the deposit, find and trace additional high-grade shoots, and make new discoveries within the footprint of the Twin Hills gold system and also the remainder of the Karibib trend," the firm said. Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF) is bringing a reformulated version of its leading CBD brand Sollievo to the market.  Sollievo, which in Italian means ‘relief,’ is a non-GMO, non-psychoactive CBD tincture that has rapid bioavailability and derived from USA-grown hemp. The updated formulations contain three times the amount of CBD per unit, packing a more potent punch in each dosage. Medexus Pharmaceuticals Inc (CVE:KMDP) (OCTMKTS:PDDPF) reported financial results for the three and nine-month periods ended on December 31, 2019 that saw revenue of C$16.2 million and C$48.7 million respectively, showing strong demand for its products. In a statement, accompanying the latest numbers, Medexus Pharmaceuticals CEO Ken d’Entremont, noted: “This improvement reflects both the acquisitions in October 2018, as well as continued unit demand growth across our key products.” Ximen Mining Corp (CVE:XIM) (OTCMKTS:XXMMF) has posted results from the analysis of drill core and samples by previous operators at the Kenville gold mine at Nelson in British Columbia. It reportedly produced 65,236 oz gold from 158,842 tonnes processed, and 27,686 ounces of silver intermittently between 1889 and 1956. The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF), the organic cannabis group, has reached another milestone, namely a research licence from Health Canada. The license will reduce costs and accelerate the firm's development of new products by eliminating reliance on third parties, it told investors in a statement. VolitionRx Limited (NYSEAMERICAN:VNRX) said it will host a conference call on Friday, February 21 at 8:30am Eastern time to discuss its financial and operating results for the fourth quarter and full-year 2019. The group noted that Cameron Reynolds, Volition’s president and chief executive officer will host the call along with David Vanston, chief financial officer and Scott Powell, executive vice president, Investor Relations. It said the call will provide an update on recent developments and Volition's activities, including details of new and ongoing clinical trials, important events which have taken place in 2019, and milestones for 2020 and beyond. A live audio webcast of the conference call will also be available on the investor relations page of Volition's corporate website. Mandalay Resources Corporation (TSX:MND) (OTCMKTS:MNDJF) said it will release its fourth quarter and full-year 2019 financial results after the market close on February 20, 2020. It said this will be followed by a conference call with Dominic Duffy, Mandalay’s president and chief executive officer for investors and analysts on February 21, 2020 at 8:00am (Toronto time). Nextleaf Solutions (CSE:OILS) (OTCMKTS:OILFF), the Vancouver-based cannabis firm focused on developing disruptive intellectual property for industrial-scale extraction, today announced that its CEO, Paul Pedersen will present live at VirtualInvestorConferences.com on Thursday, February 20 at 1:00pm Easter Time. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. BioPorto A/S (CPH:BIOPOR) said it will hold an investor meeting on February 26, 2020, at 3 pm. at BioPorto’s address Tuborg Havnevej 15, st., 2900 Hellerup, Denmark, in connection with the release of the firm’s 2019 annual report. The group said registration for participation can be made by emailing investor@BioPorto.com Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, has announced that it will participate in two upcoming investor conferences in March 2020. The group said Dr. Raj Mehra, its chairman and CEO, will present at the Cowen 40th Annual Health Care Conference on Wednesday, March 4 at 8:40am Eastern Time. It added that Dr. Mehra will also participate at the Roth Capital 32nd Annual Conference and present on Tuesday, March 17th at 8:00am Pacific Time. Aequus Pharmaceuticals Inc. (CVE:AQS) (OTCMKTS:AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced that, further to its news release on February 3, 2020, Stuart Fowler has now been formally appointed to its board of directors. In connection with Fowler's appointment and his new role as strategic advisor to Aequus’ commercial team, the company has granted him 350,000 incentive stock options. The company said it has also granted 100,000 incentive stock options to an employee of the company who is focused on the branding and launch preparation of the Evolve product line. It said these stock options are exercisable at a price of $0.13 per share, for a term of eight years, and vest in tranches during the next three years. EnWave Corporation (CVE:ENW), a global leader in vacuum microwave dehydration technology, said it will report its financial results for the first quarter of fiscal year 2020 after the market close on Tuesday, February 25.